Treatment response to erenumab in refractory migraine patients

被引：0
|
作者：
Messina, R.
Cetta, I.
Guerrieri, S.
Colombo, B.
Filippi, M.
机构：
[1] IRCCS San Raffaele Sci Inst, Neurol Unit, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO2161
引用
收藏
页码：864 / 864
页数：1
相关论文
共 50 条
  • [41] Erenumab in Mechanism-based Migraine Treatment
    Ozge, Aynur
    Uluduz, Derya
    Karadas, Omer
    Bozkurt, Manal Mehtar
    TURKISH JOURNAL OF NEUROLOGY, 2021, 27 (03) : 229 - 239
  • [42] Two Year Real World Prospective Quality of Life Data in Treatment Refractory Chronic Migraine Patients Treated with Erenumab in Ireland
    Troy, E.
    Shrukalla, A. A.
    Buture, A.
    Conaty, K.
    Macken, E.
    Lonergan, R.
    Melling, J.
    Long, N.
    Shaikh, E.
    Tomkins, E.
    Ruttledge, M.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 181 - 181
  • [43] Response to erenumab and onabotulinumtoxinA: comparative analysis in two cohorts of chronic migraine patients
    Torres-Ferrus, Marta
    Caronna, Edoardo
    Alpuente, Alicia
    Mas-de-les-Valls, Ruth
    Gine-Cipres, Eulalia
    Pozo-Rosich, Patricia
    CEPHALALGIA, 2023, 43 (1supp)
  • [44] Chronic Migraine Treatment with Erenumab: Responder Rates
    Brandes, J. L.
    Diener, H.
    Dolezil, D.
    Freeman, M. C.
    McAllister, P. J.
    Winner, P.
    Cheng, S.
    Leonardi, D. K.
    Lenz, R. A.
    Mikol, D. D.
    HEADACHE, 2017, 57 : 197 - 198
  • [45] Erenumab Safe, Effective for Patients With Migraine With Aura
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (09): : 804 - 804
  • [46] Cardiovascular Safety of Erenumab in Patients with Migraine and Aura
    Ashina, M.
    Goadsby, P. J.
    Dodick, D. W.
    Tepper, S. J.
    Xue, F.
    Zhang, F.
    Olearczyk, J. J.
    Lima, Paiva da Silva G.
    HEADACHE, 2020, 60 : 101 - 102
  • [47] Pharmacokinetics and Safety of Erenumab in Pediatric Patients With Migraine
    Hershey, A.
    Lima, G. Paiva da Silva
    Pannacciulli, N.
    Mackowski, M.
    Koukakis, R.
    Khodavirdi, A.
    McVige, J.
    HEADACHE, 2023, 63 : 151 - 152
  • [48] A prospective real-world analysis of erenumab in refractory chronic migraine
    Lambru, Giorgio
    Hill, Bethany
    Murphy, Madeleine
    Tylova, Ivona
    Andreou, Anna P.
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [49] Retrospective Real-World Evaluation Of Erenumab In Refractory Chronic Migraine
    Ong, Hui Ching
    Ghadiri-Sani, Mona
    CEPHALALGIA, 2023, 43 (1supp)
  • [50] Patient characteristics and treatment patterns for migraine patients initiating erenumab in Denmark and Sweden
    Reutfors, Johan
    Leon, Sandra Lopez
    Kousholt, Astrid
    Linder, Marie
    Bjork, Marte-Helene H.
    Sundholm, Anna
    Hoti, Fabian
    Bach, Flemming Winther
    Ehrenstein, Vera
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 451 - 451
12345